skip navigation


Register for Latest Research

Stay Informed
Register with NCJRS to receive NCJRS's biweekly e-newsletter JUSTINFO and additional periodic emails from NCJRS and the NCJRS federal sponsors that highlight the latest research published or sponsored by the Office of Justice Programs.

NCJRS Abstract

The document referenced below is part of the NCJRS Virtual Library collection. To conduct further searches of the collection, visit the Virtual Library. See the Obtain Documents page for direction on how to access resources online, via mail, through interlibrary loans, or in a local library.


NCJ Number: 199940 Add to Shopping cart Find in a Library
Title: Relationship Between Platelet Serotonin Uptake Sites and Treatment Outcome Among African-American Cocaine Dependent Individuals
Journal: Journal of Addictive Diseases  Volume:22  Issue:1  Dated:2003  Pages:79-92
Author(s): Ashwin A. Patkar M.D.; Edward Gottheil M.D.; Wade H. Berrettini M.D.; Charles C. Thornton Ph.D.; Kevin P. Hill M.D.; Stephen P. Weinstein Ph.D.
Date Published: 2003
Page Count: 14
Sponsoring Agency: National Institute on Drug Abuse
Bethesda, MD 20892-9561
Grant Number: KO8DA00340-02
Type: Report (Study/Research)
Format: Article
Language: English
Country: United States of America
Annotation: This study examined whether platelet tritiated paroxetine binding, a measure of serotonin uptake sites, differed between cocaine-dependent subjects and controls, and whether paroxetine binding was related to treatment outcome for cocaine patients.
Abstract: Considerable evidence has accumulated in the last decade to indicate that in addition to the mesolimbic dopamine system, serotonergic mechanisms may be involved in mediating the central effects of cocaine. Acutely, cocaine has been found to strongly inhibit serotonin uptake and increase extracellular serotonin, and repeated administration of cocaine has been shown to reduce serotonin levels in neurons. In order to test such evidence, a total of 125 African-American cocaine-dependent individuals who were receiving outpatient treatment were studied, along with 44 African-American controls recruited from local advertisements. Consenting and screening procedures were similar for all subjects, and control subjects were excluded if they had a history of substance abuse (except tobacco), a major psychiatric disorder, a positive urine drug screen, or were taking psychotropic medications. Tritiated paroxetine binding sites on platelets were assayed, and standardized assessments of behavior were performed. The outcome measures were number of negative urine drug screens, days in treatment, dropout rates, and number of treatment sessions attended. Cocaine patients were found to have significantly lower Bmax values of paroxetine binding compared to controls. Furthermore, Bmax values showed a significant positive correlation with days in treatment and negative urines. A combination of Bmax and Addiction Severity Index (ASI) employment scores improved the prediction of days in treatment, and a combination of Bmax and ASI drug scores enhanced the prediction of negative urines. These findings indicate that serotonergic mechanisms may be involved in cocaine dependence and may influence treatment outcome for cocaine patients. 1 table and 54 references
Main Term(s): Drug dependence
Index Term(s): Black/African Americans; Cocaine; Drug abuse causes; Treatment effectiveness
To cite this abstract, use the following link:

*A link to the full-text document is provided whenever possible. For documents not available online, a link to the publisher's website is provided. Tell us how you use the NCJRS Library and Abstracts Database - send us your feedback.